Relmada Therapeutics (RLMD)
(Delayed Data from NSDQ)
$3.64 USD
+0.11 (3.12%)
Updated May 14, 2024 04:00 PM ET
After-Market: $3.66 +0.02 (0.55%) 7:58 PM ET
2-Buy of 5 2
F Value A Growth A Momentum C VGM
Earnings News For RLMD
-
Relmada Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results
-
Relmada Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results
-
Relmada Therapeutics Provides Corporate Update and Reports Third Quarter 2023 Financial Results
-
Relmada Therapeutics Provides Corporate Update and Reports Second Quarter 2023 Financial Results
-
Relmada Therapeutics Provides Corporate Update and Reports First Quarter 2023 Financial Results
-
Relmada Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2022 Financial Results
-
Relmada Therapeutics Provides Corporate Update and Reports Third Quarter 2022 Financial Results